This article by Elisabetta Fato was originally published on Microdose and appears here with permission.
In the last decades, there has been a growing interest in psychedelics for the treatment of mood and behavioral disorders, among which are substance use disorders.
Article by Jason Najum.
Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the industry to mature.